THIS IS AN ASPIRE PHARMA WEBSITE PAGE INTENDED FOR UK PATIENTS WHO HAVE BEEN PRESCRIBED REPINEX XL^® (ROPINIROLE)

Repinex XL^{^®} (ropinirole)

Prolonged-release tablets

About Repinex XL About Parkinson’s Resources

About Repinex XL^®

Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL)

The following links will take you to the electronic Medicines Compendium (eMC) website.

By using the links below, you will leave the Pathway Portfolio website and be re-directed to an external site. Aspire Pharma is not responsible for the content on external websites.

Repinex XL 2mg prolonged release tablets

View the SmPC

View the PIL

Repinex XL 4mg prolonged release tablets

View the SmPC

View the PIL

Repinex XL 8mg prolonged release capsules

View the SmPC

View the PIL

What is Parkinson’s Disease?

Definition

Parkinson’s disease is a condition in which parts of the brain become progressively damaged over many years.¹Parkinson’s disease is caused by a loss of nerve cells in part of the brain called the substantia nigra. This leads to a reduction in a chemical called dopamine in the brain.^1,2

Dopamine plays a vital role in regulating the movement of the body. A reduction in dopamine is responsible for many of the symptoms of Parkinson’s disease. Exactly what causes the loss of nerve cells is unclear. Most experts think that a combination of genetic and environmental factors is responsible.¹

Types of symptoms

Parkinson’s disease is a chronic neurodegenerative disorder, causing impaired motor function with slow movements, tremor and gait and balance problems. Various non-motor symptoms are common and and include depression, anxiety, impulse control disorders, psychotic symptoms, dementia, sleep disturbance, constipation, orthostatic hypotension (drop in blood pressure when standing up), and pain.³

Most people with Parkinson’s start to develop symptoms when they’re over 50, although some people with the condition first experience symptoms when they’re under 40.¹

The three main symptoms of Parkinson’s disease affect physical movement:⁴

Tremor – shaking, which usually begins in the hand or arm and is more likely to occur when the limb is relaxed and resting.

Slowness of movement (bradykinesia) – where physical movements are much slower than normal, which can make everyday tasks difficult and can result in a distinctive slow, shuffling walk with very small steps.

Muscle stiffness (rigidity) – stiffness and tension in the muscles, which can make it difficult to move around and make facial expressions, and can result in painful muscle cramps (dystonia)

What causes the loss of nerve cells?

It’s not known why the loss of nerve cells associated with Parkinson’s disease occurs, although research is ongoing to identify potential causes. Currently, it’s believed a combination of genetic changes and environmental factors may be responsible for the condition.¹

A number of genetic factors have been shown to increase a person’s risk of developing Parkinson’s disease, although exactly how these make some people more susceptible to the condition is unclear.⁵
Most people with Parkinson’s start to develop symptoms when they’re over 50, although some people with the condition first experience symptoms when they’re under 40.¹Men are slightly more likely to get Parkinson’s disease than women.¹
Some researchers also feel environmental factors may increase a person’s risk of developing Parkinson’s disease. It’s been suggested that pesticides and herbicides used in farming and traffic or industrial pollution may contribute to the condition. But the evidence linking environmental factors to Parkinson’s disease is inconclusive.⁵

Resources

By using the link below you will leave the Pathway Portfolio website and be re-directed to an external site; Aspire Pharma is not responsible for the content on external websites.